Imaging Studies II: Positron Emission Tomography and Scintigraphy
Tumor Immunotherapy
Radiological Investigation III: Pulmonary Angiogram and PET Scan
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 29, 2025
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Julian L Goggi1, Siddesh V Hartimath2, Youyi Hwang3
1Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A*STAR), 11 Biopolis Way, #01-02 Helios, Singapore, 138667, Singapore. julian_goggi@sbic.a-star.edu.sg.
A novel imaging agent, [68Ga]Ga-mNOTA-GZP, effectively predicts cancer immunotherapy response by correlating with CD8+ T cell changes. This biomarker aids in patient stratification and reduces treatment side effects.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: